Opsonophagocytic assay as a potentially useful tool for assessing safety of enterococcal preparations

International Journal of Food Microbiology

Volumn 88, Issue 2-3, 2003, Pages 263-267

  Hufnagel, Markus ^a   Koch, Steffi ^a   Kropec, Andrea ^a   Huebner, Johannes ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Enterococcus; Opsonophagocytosis; Probiotics; Safety

Indexed keywords

PROBIOTIC AGENT;

BACTERIAL CELL; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOASSAY; BIOSAFETY; BLOOD FLOW; CELL KILLING; CONFERENCE PAPER; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; FOOD BIOTECHNOLOGY; HOST; HUMAN; IMMUNE RESPONSE; NONHUMAN; PHAGOCYTOSIS;

ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ORYCTOLAGUS CUNICULUS;

EID: 0142227680     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(03)00189-2     Document Type: Conference Paper

References (19)

1. Aarestrup F.M., Butaye P., Witte W. Nonhuman reservoirs of enterococci. Gilmore M.S. The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance. 2002;55-99 ASM Press, Washington, DC.
2. Arduino R.C., Murray B.E., Rakita R.M. Roles of antibodies and complement in phagocytic killing of enterococci. Infect. Immun. 62:1994;987-993.
3. Chow J.W., Thal L.A., Perri M.B., Vazquez J.A., Donabedian S.M., Clewell D.B., Zervos M.J. Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 37:1993;2474-2477.
4. Franz C.M., Muscholl-Silberhorn A.B., Yousif N.M., Vancanneyt M., Swings J., Holzapfel W.H. Incidence of virulence factors and antibiotic resistance among enterococci isolated from food. Appl. Environ. Microbiol. 67:2001;4385-4389.
5. Huebner J., Wang Y., Krueger W.A., Madoff L.C., Martirosian G., Boisot S., Goldmann D.A., Kasper D.L., Tzianabos A.O., Pier G.B. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect. Immun. 67:1999;1213-1219.
6. Huebner J., Quaas A., Krueger W.A., Goldmann D.A., Pier G.B. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect. Immun. 68:2000;4631-4636.
7. Jett B.D., Huycke M.M., Gilmore M.S. Virulence of enterococci. Clin. Microbiol. Rev. 7:1994;462-478.
8. Maekawa S., Yoshioka M., Kumamoto Y. Proposal of a new scheme for the serological typing of Enterococcus faecalis strains. Microbiol. Immunol. 36:1992;671-681.
9. Mundy L.M., Sahm D.F., Gilmore M. Relationships between enterococcal virulence and antimicrobial resistance. Clin. Microbiol. Rev. 13:2000;513-522.
10. Murray B.E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:2000;710-721.
11. Pier G.B., DesJardin D., Grout M., Garner C., Bennett S.E., Pekoe G., Fuller S.A., Thornton M.O., Harkonen W.S., Miller H.C. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infect. Immun. 62:1994;3972-3979.
12. Pier G.B., Koles N.L., Meluleni G., Hatano K., Pollack M. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infect. Immun. 62:1994;1137-1143.
13. Sahm D.F., Kissinger J., Gilmore M.S., Murray P.R., Mulder R., Solliday J., Clarke B. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1989;1588-1591.
14. Salyers A.A., Whitt D.D. Bacterial Pathogenesis: A Molecular Approach. 2002;ASM Press, Washington, DC.
15. Schlievert P.M., Gahr P.J., Assimacopoulos A.P., Dinges M.M., Stoehr J.A., Harmala J.W., Hirt H., Dunny G.M. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect. Immun. 66:1998;218-223.
16. Wang Y., Huebner J., Tzianabos A.O., Martirosian G., Kasper D.L., Pier G.B. Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydr. Res. 316:1999;155-160.
17. Wells C.L., Jechorek R.P., Erlandsen S.L. Evidence for the translocation of Enterococcus faecalis across the mouse intestinal tract. J. Infect. Dis. 162:1990;82-90.
18. Wells C.L., Jechorek R.P., Gillingham K.J. Relative contributions of host and microbial factors in bacterial translocation. Arch. Surg. 126:1991;247-252.
19. Xu Y., Murray B.E., Weinstock G.M. A cluster of genes involved in polysaccharide biosynthesis from Enterococcus faecalis OG1RF. Infect. Immun. 66:1998;4313-4323.